Scholarlink

<p>The Igbo-Ora virus, a member of the Alphavirus genus within the Togaviridae family, is an arthropod-borne virus (arbovirus) primarily transmitted by mosquitoes and known to cause febrile illness in humans. This study aims to design two mRNA vaccine constructs targeting the virus’s non-structural polyproteins using an integrative strategy that combines immunoinformatics approaches. Viral sequences were retrieved from NCBI and analyzed for antigenicity, allergenicity, toxicity, B-cell epitopes, CD8+T lymphocytes (CTL), and CD4+T lymphocytes (HTL). These epitopes, along with additional co-translational residues, were used to develop the mRNA vaccine constructs. Physicochemical analysis revealed that both constructs exhibited good stability, thermostability, and solubility. Molecular docking studies demonstrated strong binding affinities between the vaccine constructs and Toll-like receptors (TLR-3 and TLR-7). Immunological simulations indicated significant activation of CD4+ and CD8+T cells, natural killer cells, and antigen-presenting cells. Further in vitro and in vivo validation studies are essential to confirm these findings and advance the development of a safe and effective vaccine against the Igbo-Ora virus, contributing to global public health preparedness and pandemic prevention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rational mRNA vaccine design against igbo-ora virus through immunoinformatic profiling of non-structural polyproteins

  • 期刊论文

  • 发表日期：

    2025年12月26日

查看全文
  • Elijah Kolawole Oladipo,
  • James Akinwumi Ogunniran,
  • Oluwaseyi Samuel Akinpelu,
  • Moses Chinecherem Ugwuja,
  • Olumide Faith Ajani,
  • Simeon Kayowa Olatunde,
  • Elukunbi Hilda Awoyelu,
  • Olatunji Matthew Kolawole

摘要

The Igbo-Ora virus, a member of the Alphavirus genus within the Togaviridae family, is an arthropod-borne virus (arbovirus) primarily transmitted by mosquitoes and known to cause febrile illness in humans. This study aims to design two mRNA vaccine constructs targeting the virus’s non-structural polyproteins using an integrative strategy that combines immunoinformatics approaches. Viral sequences were retrieved from NCBI and analyzed for antigenicity, allergenicity, toxicity, B-cell epitopes, CD8+T lymphocytes (CTL), and CD4+T lymphocytes (HTL). These epitopes, along with additional co-translational residues, were used to develop the mRNA vaccine constructs. Physicochemical analysis revealed that both constructs exhibited good stability, thermostability, and solubility. Molecular docking studies demonstrated strong binding affinities between the vaccine constructs and Toll-like receptors (TLR-3 and TLR-7). Immunological simulations indicated significant activation of CD4+ and CD8+T cells, natural killer cells, and antigen-presenting cells. Further in vitro and in vivo validation studies are essential to confirm these findings and advance the development of a safe and effective vaccine against the Igbo-Ora virus, contributing to global public health preparedness and pandemic prevention.